SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Martek Biosciences---- future biotech cash cow!

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: RagTimeBand who wrote (76)7/16/1997 10:46:00 PM
From: Machaon   of 258
 
Ho HA! Another human being shows up on this thread.

If you want to read an interesting article about Martek read this:

biz.yahoo.com

That's the article that got me interested in this stock. But, their last earnings report was kinda rotten, $1 million in revenues and about $4.5 million in losses.

But, it showed that sales were picking up. They are now selling in about 10 foreign countries. Their Formulaid product seems to have passed tests for safety. And, their oils seem to be more effective than their competition, IMHO.

Their margins were bad due to "low volume production problems" and "low prices". They've got to keep prices down because their target audience, new mothers worldwide, aren't rolling over in dough.

I'm positive on MATK because, I think, they have solved their volume problems by stoking up the fires on their new oil facility, which will better enable them to keep prices down.

The target audience for Formulaid is HUGE! Sales seem to be increasing overseas. Can they keep prices down and increase margins to make a nice profit? Interesting question?!

Regards, Bob
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext